Skip to main content
. 2018 Jul 10;10(7):884. doi: 10.3390/nu10070884

Table 1.

Baseline participant characteristics * overall and stratified by intervention status.

Overall Magnesium (400 mg Daily) Placebo p-Value
N 59 29 30
Demographics
Age, years 61.5 ± 5.2 61.3 ± 5.3 61.6 ± 5.2 0.814
Age category 0.761
 ≥65 years 14 (23.7) 6 (20.7) 8 (26.7)
 <65 years 45 (76.3) 23 (79.3) 22 (73.3)
Sex 0.039
 Female 43 (72.9) 25 (86.2) 18 (60.0)
 Male 16 (27.1) 4 (13.8) 12 (40)
Race 0.612
 White 56 (94.9) 27 (93.1) 29 (96.7)
 Nonwhite 3 (5.1) 2 (6.9) 1 (3.3)
Educational attainment 0.279
 High school graduate or GED 1 (1.7) 0 (0) 1 (3.3)
 Some college 10 (16.9) 6 (20.7) 4 (13.3)
 College graduate 26 (44.1) 10 (34.5) 16 (53.3)
 Graduate school or professional school 22 (37.3) 13 (44.8) 9 (30)
Physiologic characteristics
Height, cm 167.9 (9.2) 167.1 (8.1) 168.7 (10.3) 0.491
Weight, kg 79.2 (18.2) 78.0 (18.0) 80.5 (18.7) 0.603
BMI, kg/m2 27.9 ± 4.6 27.7 ± 4.9 28.0 ± 4.5 0.804
Serum magnesium, mEq/L 1.72 ± 0.11 1.74 ± 0.12 1.71 ± 0.10 0.308
Systolic blood pressure, mmHg 119 ± 16 119 ± 14 119 ± 18 0.933
Diastolic blood pressure, mmHg 71 ± 9 72 ± 9 71 ± 10 0.627
Antihypertensive medication 14 (24) 9 (31) 5 (17) 0.233
Serum glucose, mg/dL 98.9 ± 29.9 94.2 ± 10.6 103.2 ± 40.2 0.242
 Sensitivity analysis ** 95.2 ± 11.1 94.2 ± 10.6 96.2 ± 11.6 0.494
Glucose lowering medication 2 (3.4) 0 (0) 2 (6.7) 0.492
PAC burden, episodes/h 14.5 ± 58 8.5 ± 14 20.2 ± 80 0.437
 Median (25th, 75th percentiles) 2.28 (1.22, 6.86) 3.64 (1.31, 7.57) 1.75 (1.12, 4.01)
Log PAC burden, log(episodes/h) 1.15 ± 1.42 1.26 ± 1.35 1.04 ± 1.49 0.566
 Median (25th, 75th percentiles) 0.82 (0.20, 1.92) 1.29 (0.27, 2.02) 0.55 (0.11, 1.39)

GED, general education diploma; BMI, body mass index; PAC, premature atrial contractions; and SD, standard deviation. * mean ± SD or n (%). ** Omission of one participant with a baseline glucose value of 307 mg/dL.